Patients who developed bladder cancer after being prescribed the diabetes medication Actos (brand name for the drug pioglitazone) have filed lawsuits against the manufacturer of Actos charging that it did not adequately warn of its cancer risks. Drug makers have a duty to warn of all serious side effects from their medications. These videos discuss the link between Actos and bladder cancer and summarize the charged made in the Actos bladder cancer lawsuits.
Actos is manufactured by Japan-based Takeda Pharmaceutical Company, Ltd.
April 2015 Update: $2.4 Billion Actos Settlement Announced
On April 28, 2015, U.S. District Court Judge Rebecca F. Doherty, the judge overseeing the Actos injury cases in federal court nationwide, issued an order recognizing that Takeda, the manufacturer of Actos, has agreed to settle most bladder cancer claims brought against the company by Actos users.
Actos Lawsuit Video
Attorney Wendy Fleishman provides an update on Actos Side Effects and Bladder Cancer Risks
Learn More About Actos Risks & Injuries
Diabetes patients can learn more about Actos risks and the rights of people injured by Actos on Lieff Cabraser’s Actos Diabetes Bladder Cancer case page.
By Wendy Fleishman.